Luke Chen, co-founder and CEO of PuriBlood, speaks about the innovative spin-off technology developed at the R&D Center for Membrane Technology at Chung Yuan Christian University. The company’s leukocyte reduction filters have the capacity to purify blood samples twice as fast as current market standards. The samples are able to be applied in multiple areas such as plasma product development.
[Our technology] will be extremely beneficial to blood banks as they can better manage their inventory rather than having to prepare large stockpiles
